Great news!

Yesterday (Thursday), the U.S. House of Representatives passed S. 1674, the Improving Access to Clinical Trials Act. Following last month's passage by the U.S. Senate, the bill now heads to the President's desk to be signed into law.

This bill will allow people with CF to participate in important clinical research without losing their public health coverage. By removing barriers to participation in clinical trials, we can speed the development of promising new CF therapies and get them into the hands of the patients who need them.

The Cystic Fibrosis Foundation identified a significant barrier to participation in clinical trials and worked with Congress to write this common sense legislation.

This momentous achievement, almost five years in the making, would not have been possible without the thousands of letters written, calls made, and meetings held by dedicated CF Advocates like you.



YAY!!!

Senate Passes Clinical Trials Act!

This past Thursday night, the U.S. Senate passed S. 1674, the Improving Access to Clinical Trials Act, by unanimous consent.

All that remains now is for the House of Representatives to pass the bill as well. Even if you have already asked your Representative to sign on to the bill as a co-sponsor by clicking here. Now is the time to tell the House to pass the Improving Access to Clinical Trials Act.

The Improving Access to Clinical Trials Act would allow people with CF who are on public benefits to participate in important clinical research without losing their health coverage. To help promising drugs move swiftly from the research and testing phase to the people who need them, more people with cystic fibrosis are needed to participate in clinical trials. This important legislation will remove barriers to allow more people to do so.

Tell your Representative to pass the Improving Access to Clinical Trials Act today!